Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsIn the revolutionary field of CAR-T cell therapy, the specificity and affinity of the antigen-binding domain are paramount to achieving potent and targeted anti-tumor efficacy. The discovery of the ideal single-chain variable fragment (scFv) or single-domain antibody (sdAb/VHH) is a critical, yet often time-consuming and resource-intensive, step. Creative Biolabs, a recognized leader in antibody engineering for over two decades, provides a superior solution: Premade Antibody Library based Antibody Discovery Services. By leveraging our vast, high-diversity, and ready-to-screen antibody libraries, we empower researchers to bypass the lengthy process of library construction and accelerate the identification of optimal binders for their CAR-T candidates.
In recent years, chimeric antigen receptor (CAR)-T cell therapy has emerged as a highly promising strategy for the treatment of hematological malignancies. CARs are synthetic fusion proteins that combine an antigen-recognition domain—typically a single-chain variable fragment (scFv) derived from an antibody—with intracellular signaling domains responsible for T cell activation. Engineered T cells expressing CARs can recognize and eliminate tumor cells in a major histocompatibility complex (MHC)-independent manner. Numerous clinical trials have demonstrated that CAR-T cell-based adoptive immunotherapy can induce durable remissions in patients with hematologic cancers, often surpassing outcomes achieved with conventional combination therapies.
Fig.1 Overview of chimeric receptor (CAR) T-cell therapy.1
Traditional antibody discovery methods, such as hybridoma technology or custom library construction, can take months to yield viable candidates. Our premade antibody libraries offer a strategic advantage, providing immediate access to a wealth of diverse antibody repertoires. This approach not only saves valuable time and resources but also increases the probability of identifying unique binders with superior therapeutic potential.
| Feature | Creative Biolabs' Premade Libraries | Traditional Methods (e.g., Hybridoma) |
| Discovery Timeline | 4-6 Weeks to Initial Hits | 3-6+ Months |
| Library Diversity | >1010 Unique Clones | Limited to Host Immune Response |
| Target Compatibility | Broad (Proteins, Peptides, Cells) | Often Challenging for Toxic or Poorly Immunogenic Targets |
| Humanization Needs | Reduced/Eliminated with Human Libraries | Often Required, Adding Time & Cost |
| Binder Format | Flexible (scFv, Fab, VHH/sdAb) | Primarily Full-Length IgG |
Our expertise is built on a foundation of state-of-the-art display technologies. We have meticulously constructed and validated a suite of premade libraries utilizing the most powerful selection systems in the industry.
Phage display remains a gold standard for in vitro antibody selection. Our premade phage display libraries are among the largest and most diverse available, featuring human and camelid antibodies in various formats.
For targets that require eukaryotic post-translational modifications or for projects demanding nuanced affinity-based sorting, our yeast display platform offers unparalleled precision.
Creative Biolabs offers an extensive collection of premade libraries to suit your specific CAR-T research needs.
| Library Type | Format | Species | Diversity | Key Advantages for CAR-T |
| Human Naïve Library | scFv, Fab | Human | >1011 | Reduces immunogenicity risk; no humanization needed. |
| Human Synthetic Library | scFv, Fab | Human | >1011 | Optimized frameworks for stability and expression. |
| Camelid VHH Library | VHH (sdAb) | Llama | >1010 | Small size, high stability, excellent for unique epitopes. |
| Immune Libraries | scFv, Fab, VHH | Mouse, Rabbit, Alpaca | >108 | High-affinity binders against specific immunized targets. |
Creative Biolabs offers a diverse portfolio of libraries to suit any CAR-T discovery project.
| Libraries | Library ID | Display Technology | Library Format | Species | Library Size |
| Phage display human scFv libraries | HuScL-2 | Phage Display | scFv | Human | 1.42×109 |
| HuScL-4 | Phage Display | scFv | Human | 2.0×109 | |
| HuScL-6 | Phage Display | scFv | Human | 1.0×1011 | |
| HuScL-7 | Phage Display | scFv | Human | 1.1×1010 | |
| Phage display human Fab libraries | HuFabL-4 | Phage Display | Fab | Human | 1.9×1010 |
| HuFabL-5 | Phage Display | Fab | Human | 1.1×1010 | |
| HuFabssL-1 | Phage Display | Fab | Human | 1.8×1010 |
Creative Biolabs also provides antibody discovery services for different types of targets to suit a variety of applications:
Our service is designed to be a seamless extension of your research team, delivering rapid and reliable results.
Partner with a global leader in antibody discovery. Contact our team of experts to discuss your project and learn how our premade antibody libraries can accelerate your path to the clinic.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
